Pevonedistat and Azacitidine in MDS or MDS/MPN Patients Who Fail Primary Therapy With DNA Methyl Transferase Inhibitors

NCT03238248 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

71

Enrollment

OTHER

Sponsor class

Conditions

Myelodysplastic Syndromes
Myeloproliferative Neoplasm

Interventions

DRUG: Azacitidine Subcutaneous Injection or Intravenous Infusion
DRUG: Pevonedistat Infusion
PROCEDURE: Bone Marrow Biopsy & Aspirate

Sponsor

Vanderbilt-Ingram Cancer Center

Collaborators

[object Object]